Deferred Tax Assets, Valuation Allowance of IceCure Medical Ltd. from 31 Dec 2020 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
IceCure Medical Ltd. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2020 to 31 Dec 2024.
  • IceCure Medical Ltd. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $21,699,000, a 16% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

IceCure Medical Ltd. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $21,699,000 +$2,946,000 +16% 31 Dec 2024 20-F 27 Mar 2025 2024 FY
Q4 2023 $18,753,000 +$1,443,000 +8.3% 31 Dec 2023 20-F 27 Mar 2025 2024 FY
Q4 2022 $17,310,000 +$3,103,000 +22% 31 Dec 2022 20-F 03 Apr 2024 2023 FY
Q4 2021 $14,207,000 +$2,161,000 +18% 31 Dec 2021 20-F 29 Mar 2023 2022 FY
Q4 2020 $12,046,000 31 Dec 2020 20-F/A 22 Aug 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.